Skip to main navigation

+44 (0)20 8154 4600
info@achillestx.com

Home
About Us
Science
Publications
Pipeline
- PIPELINE
- EXPANDED ACCESS
Investors & Media
CAREERS
Contact

Press Releases

Home
About Us
Science
Publications
Pipeline
- PIPELINE
- EXPANDED ACCESS
Investors & Media
CAREERS
Contact

Year

All News
2024
2023
2022
2021
2020
2019
2018
2017
2016

Mar 1 2021

Achilles Therapeutics Announces Filing of Registration Statement for Proposed Initial Public Offering in the United States

Read More +

Feb 5 2021

Achilles Therapeutics Announces Additional Financing Plans

Read More +

Feb 5 2021

Achilles Therapeutics Announces Independent Data and Safety Monitoring Committee Review with a Positive Recommendation to Continue with Current Study Design of the Phase I/IIa CHIRON and THETIS Trials

Read More +

Feb 4 2021

Achilles Therapeutics Appoints Arjan Roozen as VP, Site Head and General Manager

Read More +

Jan 7 2021

Achilles Therapeutics to present at the 39th Annual J.P. Morgan Healthcare Conference

Read More +

Dec 7 2020

Achilles Therapeutics Appoints Lee M. Stern as VP, IR & External Communications

Read More +

Dec 1 2020

Achilles Therapeutics Appoints Robert Coutts as Chief Financial Officer

Read More +

Nov 19 2020

Achilles Therapeutics Raises £52.7 Million in an Oversubscribed Series C Financing to Further Advance the Development of Personalised T cell Therapies to Treat Solid Tumours

Read More +

Nov 17 2020

Achilles Therapeutics Announces Grant of European Patent Covering Use of Selectively Expanded T cells Targeting Clonal Neoantigens for the Treatment of Cancer

Read More +

Oct 7 2020

Achilles Therapeutics appoints Daniel Hood as Chief Legal Officer

Read More +

Pagination

First page
Previous page
Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Current page 7
Page 8
Page 9
Next page
Last page

Print Page

RSS Feeds

Email Alerts

Contact IR

Home
About Us
Science
Publications
Pipeline
Investors & Media
Work with us
Contact

UK Headquarters:
Achilles Therapeutics plc
245 Hammersmith Road
London
W6 8PW, UK

US Headquarters:
Achilles Therapeutics US, Inc.
401 N. Broad Street
Suite M121
Philadelphia, PA 19108

+44 (0)20 8154 4600
info@achillestx.com

© Copyright - Achilles Therapeutics plc.

Achilles Therapeutics plc (13027460) is registered in England and Wales. The registered office is at 245 Hammersmith Road, London, W6 8PW.

Privacy & Cookie Policy

Terms & Conditions